Search Results

Antipsychotic drugs(APDs) have been effective to alleviate psychotic symptoms of schizophrenia. However, some schizophrenic patients do not respond to APDs. In addition to psychotic symptoms of schizophrenia, negative symptoms, excitement, violence, agitation, depression, and disorganization are frequently noted in patients with schizophrenia. Though APDs are the first line drugs for these symptoms, other drugs than APDs to augment the effects of APDs are efficacious for the treatment of these symptoms. Such augmenting drugs include benzodiazepines, anticonvulsants, antidepressants, lithium, and electroconvulsive therapy. These augmentation strategies can boost the effects of APDs or decrease the requirements of APDs, and consequently decrease the chance of the occurrence of side effects of APDs. Augmenting strategies are revewed for each class of drugs or treatment modality.
Anticonvulsants ; Antidepressive Agents ; Antipsychotic Agents ; Benzodiazepines ; Depression ; Dihydroergotamine ; Electroconvulsive Therapy ; Humans ; Lithium ; Schizophrenia* ; Violence

3.A study of relationship between defense styles and clinical symptoms II.

Sung Hak JI ; Young Ki CHUNG

Journal of Korean Neuropsychiatric Association 1991;30(2):385-393

4.Plasma Fibronectin Levels in Patients with Psoriasis.

Ki Young SUNG ; Sang Lip CHUNG

Korean Journal of Dermatology 1989;27(5):495-501

Fibronectin(FN) is a physiologic glycoprotein presenton cell surface and in connective tissue, extracellular matrix and plasma. Increased plasma FN levels have been reported in the patients with psoriasis, connective tissue disease, internal malignancy, squamous cell carcinoma and basal cell carcinoma. The author investigated the plasma FN levels in 30 patients (males 13, female 17) with psoriasis and 23 healthy subjects (male 13, female 10) by gelatin sepharose 4B affinity chromatography and Laurells rocket immunoelectrophoresis method. The results were as follows : Plasrna JN levels were 450.4+/-80.3pg/ml in the patients with psoriasis and 334.0-51.3pg/ml in healthy subjects. There was no relationship between age graups and sex. Plasrna FN levels in the patients with psoriasis were higher than those of healthy subjects(p<0.001). There was no relationship between the levels of plasma FN and clinical severity of psoriasis.
Carcinoma, Basal Cell ; Carcinoma, Squamous Cell ; Chromatography, Affinity ; Connective Tissue ; Connective Tissue Diseases ; Extracellular Matrix ; Female ; Fibronectins* ; Gelatin ; Glycoproteins ; Humans ; Immunoelectrophoresis ; Plasma* ; Psoriasis* ; Sepharose

1.A Report of the China: Korea Medical Conference, Beijing 1997 .

2.Augmentation Strategies for the Treatment of Schizophrenia.

3.A study of relationship between defense styles and clinical symptoms II.

4.Plasma Fibronectin Levels in Patients with Psoriasis.

5.Psychoneuroimmunology: stress, depression, schizophrenia and the immune system.

6.Portal hypertension in children.

7.Aeromedical analysis of flying restriction in aircrews, ROKAF.

8.Posttraumatic stress disorder and thyroid function.

9.The abnormalities of immune function ib schizophrenics(III).

10.A study of voice change after operation in unilateral vocal palsy.

Display Mode

Output Records

File Type